Log in to save to my catalogue

ECM1 is associated with endocrine resistance in ER+ breast cancers

ECM1 is associated with endocrine resistance in ER+ breast cancers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246032

ECM1 is associated with endocrine resistance in ER+ breast cancers

About this item

Full title

ECM1 is associated with endocrine resistance in ER+ breast cancers

Author / Creator

Publisher

Daejeon: Taylor & Francis

Journal title

Animal cells and systems, 2022-05, Vol.26 (3), p.99-107

Language

English

Formats

Publication information

Publisher

Daejeon: Taylor & Francis

More information

Scope and Contents

Contents

Extracellular matrix protein 1 (ECM1) is associated with a poor prognosis of breast cancers. However, the role of ECM1 with endocrine resistance in estrogen receptor-positive (ER
+
) breast cancers has not been elucidated yet. We show that ECM1 promotes endocrine resistance in ER
+
breast cancers. ECM1 is overexpressed in luminal breast...

Alternative Titles

Full title

ECM1 is associated with endocrine resistance in ER+ breast cancers

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246032

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246032

Other Identifiers

ISSN

1976-8354

E-ISSN

2151-2485

DOI

10.1080/19768354.2022.2083235

How to access this item